Heparin bonded hemodialysis e-PTFE grafts result in 20% clot free survival benefit

Journal of Vascular Access

Volumn 10, Issue 3, 2009, Pages 153-156

  Davidson, Ingemar J ^a   Hackerman, Clayton ^a   Kapadia, Aschmeeta ^a   Minhajuddib, Abu ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Graft patency; Heparing bonding artificial surfaces; PTFE hemodialysis grafts

Indexed keywords

HEPARIN; POLITEF; ANTICOAGULANT AGENT; BIOMATERIAL;

ARTICLE; BLOOD VESSEL GRAFT; CONTROLLED STUDY; DRUG COATING; GRAFT PATENCY; GRAFT SURVIVAL; HEMODIALYSIS; HUMAN; MORTALITY; VASCULAR ACCESS; ARTERIOVENOUS SHUNT; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL TRANSPLANTATION; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; GRAFT OCCLUSION; INSTRUMENTATION; KAPLAN MEIER METHOD; PATHOPHYSIOLOGY; PROSTHESIS; RENAL REPLACEMENT THERAPY; THROMBOSIS; TIME; TREATMENT OUTCOME; VASCULAR PATENCY;

ANTICOAGULANTS; ARTERIOVENOUS SHUNT, SURGICAL; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CASE-CONTROL STUDIES; COATED MATERIALS, BIOCOMPATIBLE; GRAFT OCCLUSION, VASCULAR; HEPARIN; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY FAILURE, CHRONIC; POLYTETRAFLUOROETHYLENE; PROSTHESIS DESIGN; RENAL DIALYSIS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 70350714125     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.1177/112972980901000303     Document Type: Article

References (17)

1. Larm O, Larsson R, Olsson P. A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomater Med Dev Artif Organs 1983; 11 (2 & 3): 161-73.
2. Bozdayi M, Borowiec J, Nilsson L, et al. Effects of heparin coating of cardiopulmonary bypass circuits on in vitro oxygen free radical production during coronary bypass surgery. Artif Organs 1996; 20: 1008-16.
3. Fukutomi M, Kobayashi S, Niwaya K, et al. Changes in platelet, granulocyte and complement activation during cardiopulmonary bypass using heparin-coated equipment. Artif Organs 1996; 20: 767-76.
4. Borowiec J, Thelin S, Bagge L, et al. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. J Thoracic Cardiovasc Surg 1992; 104: 642-7.
5. Kaufmann F, Hennig E, Loebe M et al. Improving the antithrombogenicity of artificial surfaces through heparin coating- clinical experience with the pneumatic extracorporeal Berlin Heart assist device. Cardiovasc Engineering 1996; 1: 40-4.
6. Serruys Pw, Emanuelsson H, van der Giessen W, et al. Heparin- coated Palmaz-Schatz stents in human coronary arteries. Circulation 1996; 93: 412-22.
7. Serruys PW, Grines CL, Stone GW, et al. Stent implantation in acute myocardial infarction using a heparin coated stent: a pilot study as a preamble to a randomized trial comparing balloon angioplasty and stenting. Int J Cardiovasc Intervent 1998; 1: 19-27.
8. Serruys PW, von Hout B, Bonnier H, et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 1998; 352: 673-81.
9. Dzavik V, Carere RG, Teo KK, et al. An open design, multicentre, randomized trial of percutaneous transluminal coronary angioplasty versus stenting, with a heparin-coated stent, of totally occluded coronary arteries: rationale, trial design and baseline patient characteristics. Can J Cardiol 1998; 14: 825-32.
10. Peeters P, Verbist J, Deloose K, et al. Results with heparin bonded polytetrafluoroethylene grafts for femoral bypasses. J Cardiovasc Surg 2006; 47: 407-13.
11. Bosiers M, Deloose K, Verbist J, et al. Heparin-bonded expanded polytetrafluoroehylene vascular graft for femoropopliteal and femorocrural bypass grafting: 1-year results. J Vasc Surg 2006; 43: 313-9.
12. Battaglia G, Tringale R, Monaca V. Retrospective comparison of a heparin bonded ePTFE graft and saphenous vein for infragenicular bypass: implications for standard treatment protocol. J Cardiovasc Surg 2006; 47: 41-7.
13. Davidson I, Gallieni M, Saxena R, et al. A patient centered decision making dialysis access algorithm. J Vasc Access 2007; 859-68.
14. Davidson IJA. PTFE bridge grafts. In: Davidson IJA, ed. Access for Dialysis: Surgical and Radiologic Procedures. 2nd Edition. Austin, TX: RG Landes 2002; 45-81.
15. Derenoncourt FJ. PTFE for A-V access: six years of experience with 310 reinforced and stretch grafts. In: Henry ML, Ferguson RM, eds. Vascular access for Hemodialysis IV. Chicago, IL: W. L. Gore & Associates, Inc. and Precept Press 1995; 286-91.
16. Hakaim AG, Scott TE. Durability of early prosthetic dialysis graft cannulation results of a prospective, nonrandomized clinical trial. J Vasc Surg 1997; 25: 1002-6.
17. Dixon B, Beck G, Vazquez M, et al. Effect of dipyridamole plus aspirin on hemodialysis graft patency. NEJM 2009; 360: 2191-201.